Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ResMed Inc. Common Stock
(NY:
RMD
)
214.44
+0.36 (+0.17%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ResMed Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Which S&P500 stocks are moving after the closing bell on Wednesday?
April 23, 2025
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session.
Via
Chartmill
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
April 23, 2025
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
A Look Ahead: ResMed's Earnings Forecast
April 22, 2025
Via
Benzinga
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
April 22, 2025
Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Beyond The Numbers: 6 Analysts Discuss ResMed Stock
March 05, 2025
Via
Benzinga
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
April 23, 2025
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.
Via
Benzinga
Topics
Government
Exposures
Political
Earnings Scheduled For April 23, 2025
April 23, 2025
Via
Benzinga
Assessing ResMed: Insights From 5 Financial Analysts
April 21, 2025
Via
Benzinga
Why RESMED INC (NYSE:RMD) is a Top Pick for Dividend Investors.
April 15, 2025
Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD).
Via
Chartmill
Which S&P500 stocks are gapping on Tuesday?
April 08, 2025
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.
Via
Chartmill
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
April 08, 2025
Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
April 03, 2025
Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why RESMED INC (NYSE:RMD) Deserves Consideration as a Quality Investment.
April 01, 2025
A fundamental analysis of (NYSE:RMD): Is RESMED INC (NYSE:RMD) suited for quality investing?
Via
Chartmill
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
March 21, 2025
Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tempted To Dump Stock? Consider Shifting To Low Vol Stocks / ETFs Instead
March 16, 2025
While plummeting stock indexes sent some investors screaming for the exits, others look to shift assets from large-cap tech stocks and cap-weighted ETFs into less volatile investments..
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
March 11, 2025
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Top S&P500 movers in Monday's session
March 10, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
March 10, 2025
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Exploring the top movers within the S&P500 index during today's session.
March 05, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive...
Via
Chartmill
Discover which S&P500 stocks are making waves on Wednesday.
March 05, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
Gapping S&P500 stocks in Wednesday's session
March 05, 2025
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends.
Via
Chartmill
2 Reasons to Like RMD and 1 to Stay Skeptical
March 04, 2025
Since September 2024, ResMed has been in a holding pattern, posting a small loss of 4.8% while floating around $233.10. The stock also fell short of the S&P 500’s 6.2% gain during that period.
Via
StockStory
Topics
Stocks
Exposures
US Equities
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
February 27, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today
February 26, 2025
Via
Benzinga
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow
February 24, 2025
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after the bell. Here’s what to look for.
Via
StockStory
Insulet Earnings: What To Look For From PODD
February 19, 2025
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Via
StockStory
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
February 19, 2025
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
Via
StockStory
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
February 12, 2025
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know.
Via
StockStory
ResMed Getting Close To Elite Stock Group Entry
February 11, 2025
ResMed also boasts a 93 Composite Rating. The best growth stocks often have a 90 or higher Composite as they begin their biggest runs.
Via
Investor's Business Daily
Stock Of The Day: Different Ways To Profit From SoundHound
February 04, 2025
Shares of SoundHound AI are trading within a range. Some traders will get involved if the stock breaks out or breaks down.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.